Ars TechnicaCenter·
To keep drug prices high, pharma has been piling up the patents
Add-on patents have increased drug patent periods from two years to over six.
Read at Ars Technica →
Technology · 1 sources covering this
To keep drug prices high, pharma has been piling up the patents
Add-on patents have increased drug patent periods from two years to over six.
Coverage spectrum
0 L · 1 C · 0 R
How 1 sources are covering this
Embed this bias spectrum on your site
Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.
<iframe src="https://statesidedaily.com/embed/cluster/56c140aefb8d4238561403f56a792e6998e31c35" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="To keep drug prices high, pharma has been piling up the patents"></iframe>